487 related articles for article (PubMed ID: 29924853)
1. Optical coherence tomography findings as a predictor of clinical course in patients with branch retinal vein occlusion treated with ranibizumab.
Shiono A; Kogo J; Sasaki H; Yomoda R; Jujo T; Tokuda N; Kitaoka Y; Takagi H
PLoS One; 2018; 13(6):e0199552. PubMed ID: 29924853
[TBL] [Abstract][Full Text] [Related]
2. Macular vessel reduction as predictor for recurrence of macular oedema requiring repeat intravitreal ranibizumab injection in eyes with branch retinal vein occlusion.
Hasegawa T; Takahashi Y; Maruko I; Kogure A; Iida T
Br J Ophthalmol; 2019 Oct; 103(10):1367-1372. PubMed ID: 30514711
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion.
Kim M; Yu SY; Kim ES; Bae SH; Park JH; Yu HG; Kwak HW
Ophthalmologica; 2012; 227(3):132-8. PubMed ID: 22212151
[TBL] [Abstract][Full Text] [Related]
4. Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion.
Bayat AH; Çakır A; Özturan ŞG; Bölükbaşı S; Erden B; Elçioğlu MN
Int J Ophthalmol; 2018; 11(9):1534-1538. PubMed ID: 30225230
[TBL] [Abstract][Full Text] [Related]
5. Twenty-Four Month Results of Intravitreal Ranibizumab for Macular Edema after Branch Retinal Vein Occlusion: Visual Outcomes and Resolution of Macular Edema.
Inagaki M; Hirano Y; Yasuda Y; Kawamura M; Suzuki N; Yasukawa T; Yoshida M; Ogura Y
Semin Ophthalmol; 2021 Oct; 36(7):482-489. PubMed ID: 33617388
[No Abstract] [Full Text] [Related]
6. Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.
Yiu G; Welch RJ; Wang Y; Wang Z; Wang PW; Haskova Z
Ophthalmol Retina; 2020 Jan; 4(1):67-76. PubMed ID: 31669329
[TBL] [Abstract][Full Text] [Related]
7. Macular function following intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion.
Nishimura T; Machida S; Tada A; Oshida E; Muto T
Doc Ophthalmol; 2019 Aug; 139(1):67-74. PubMed ID: 30980231
[TBL] [Abstract][Full Text] [Related]
8. Comparing ranibizumab, dexamethasone implant, and combined therapy for macular edema secondary to branch retinal vein occlusion: a clinical trial.
Meng L; Yang M; Jiang X; Li Y; Han X
Int Ophthalmol; 2024 Jun; 44(1):262. PubMed ID: 38913192
[TBL] [Abstract][Full Text] [Related]
9. Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion: Six-Month Results of BRIGHTER.
Tadayoni R; Waldstein SM; Boscia F; Gerding H; Pearce I; Priglinger S; Wenzel A; Barnes E; Gekkieva M; Pilz S; Monés J;
Ophthalmology; 2016 Jun; 123(6):1332-44. PubMed ID: 27039022
[TBL] [Abstract][Full Text] [Related]
10. Time course of changes in contrast sensitivity following intravitreal ranibizumab injection for branch retinal vein occlusion.
Sugiura Y; Okamoto F; Murakami T; Morikawa S; Hiraoka T; Oshika T
Jpn J Ophthalmol; 2020 Sep; 64(5):497-505. PubMed ID: 32691257
[TBL] [Abstract][Full Text] [Related]
11. Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion.
Kang HM; Chung EJ; Kim YM; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):501-8. PubMed ID: 22653439
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal PRN ranibizumab treatment for macular edemadue to branch retinal vein occlusion.
Çakmak HB; Arikan Yorgun M; Toklu Y; Mutlu M
Turk J Med Sci; 2017 Feb; 47(1):40-46. PubMed ID: 28263518
[TBL] [Abstract][Full Text] [Related]
13. RANIBIZUMAB FOR MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION: One Initial Injection Versus Three Monthly Injections.
Miwa Y; Muraoka Y; Osaka R; Ooto S; Murakami T; Suzuma K; Takahashi A; Iida Y; Yoshimura N; Tsujikawa A
Retina; 2017 Apr; 37(4):702-709. PubMed ID: 27471827
[TBL] [Abstract][Full Text] [Related]
14. Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months.
Winterhalter S; Eckert A; Vom Brocke GA; Schneider A; Pohlmann D; Pilger D; Joussen AM; Rehak M; Grittner U
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):267-279. PubMed ID: 29185099
[TBL] [Abstract][Full Text] [Related]
15. Spectral-Domain Optical Coherence Tomography-Driven Treat-and-Extend and Pro Re Nata Regimen in Patients with Macular Oedema due to Retinal Vein Occlusion: 24-Month Evaluation and Outcome Predictors.
Guichard MM; Xavier AR; Türksever C; Pruente C; Hatz K
Ophthalmic Res; 2018; 60(1):29-37. PubMed ID: 29566387
[TBL] [Abstract][Full Text] [Related]
16. Foveal Thickness Fluctuation in Anti-VEGF Treatment for Branch Retinal Vein Occlusion: A Long-term Study.
Nagasato D; Muraoka Y; Tanabe M; Nishigori N; Osaka R; Mitamura Y; Tabuchi H; Kadomoto S; Murakami T; Ooto S; Suzuma K; Tsujikawa A
Ophthalmol Retina; 2022 Jul; 6(7):567-574. PubMed ID: 35218996
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Choroidal Thickness, Foveal Avascular Zone, and Macular Capillary Density in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Ranibizumab or Aflibercept-A Prospective Study.
Huang YT; Wang I; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Bair H; Lin JM; Chen WL; Chen CH; Wu WC; Tsai YY
Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454378
[TBL] [Abstract][Full Text] [Related]
18. TIME COURSE OF CHANGES IN METAMORPHOPSIA FOLLOWING INTRAVITREAL RANIBIZUMAB INJECTION FOR BRANCH RETINAL VEIN OCCLUSION.
Sugiura Y; Okamoto F; Morikawa S; Okamoto Y; Hiraoka T; Oshika T
Retina; 2018 Aug; 38(8):1581-1587. PubMed ID: 28614133
[TBL] [Abstract][Full Text] [Related]
19. Correlation between short- and long-term effects of intravitreal ranibizumab therapy on macular edema after branch retinal vein occlusion: a prospective observational study.
Minami Y; Nagaoka T; Ishibazawa A; Yoshida A
BMC Ophthalmol; 2017 Jun; 17(1):90. PubMed ID: 28610573
[TBL] [Abstract][Full Text] [Related]
20. Macular cystic changes as predictive factor for the recurrence of macular oedema in branch retinal vein occlusion.
Tilgner E; Dalcegio Favretto M; Tuisl M; Wiedemann P; Rehak M
Acta Ophthalmol; 2017 Nov; 95(7):e592-e596. PubMed ID: 28266152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
